EMPOWER-Lung 1: Cemiplimab (CEMI) monotherapy as first-line (1L) treatment of patients ( pts) with brain metastases from advanced non-small cell lung cancer (aNSCLC) with programmed cell death-ligand 1 (PD-L1) ≥50%-3-year update

---

Kilickap S., Ozguroglu M., Sezer A., Gumus M., Bondarenko I., Gogishvili M., ...More

JOURNAL OF THORACIC ONCOLOGY, no.4, 2023 (SCI-Expanded, Scopus)

• Publication Type: Article / Abstract
• Publication Date: 2023
• Journal Name: JOURNAL OF THORACIC ONCOLOGY
• Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus, CINAHL, MEDLINE
• Istanbul University-Cerrahpasa Affiliated: No